Abbott Denied Early Win In GSK Suit Over HIV Drug Cost
Abbott Laboratories must again face a GlaxoSmithKline suit claiming a price increase violated its license allowing GSK to use an HIV drug, a North Carolina federal court has ruled, finding North...To view the full article, register now.
Already a subscriber? Click here to view full article